Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling

BACKGROUND: Tamoxifen (TAM) is widely used in the chemotherapy of breast cancer and as a preventive agent against recurrence after surgery. However, extended TAM administration for breast cancer induces increased VEGF levels in patients, promoting new blood vessel formation and thereby limiting its...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, B N Prashanth, Rajput, Shashi, Dey, Kaushik Kumar, Parekh, Aditya, Das, Subhasis, Mazumdar, Abhijit, Mandal, Mahitosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681557/
https://www.ncbi.nlm.nih.gov/pubmed/23731702
http://dx.doi.org/10.1186/1471-2407-13-273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681557/
https://www.ncbi.nlm.nih.gov/pubmed/23731702
http://dx.doi.org/10.1186/1471-2407-13-273

Ejemplares similares